The ROE as of November 2024 (TTM) for Co-Diagnostics, Inc. (CODX) is -54.95%

According to Co-Diagnostics, Inc.’s latest financial reports and current stock price. The company's current ROE is -54.95%. This represents a change of 302.19% compared to the average of -13.66% of the last 4 quarters.

Co-Diagnostics, Inc. (CODX) Historical ROE (quarterly & annually)

How has CODX ROE performed in the past?

The mean historical ROE of Co-Diagnostics, Inc. over the last ten years is -41.39%. The current -54.95% ROE has changed 32.75% with respect to the historical average. Over the past ten years (40 quarters), CODX's ROE was at its highest in in the December 2018 quarter at 184.00%. The ROE was at its lowest in in the September 2018 quarter at -1288.65%.

Co-Diagnostics, Inc. (CODX) ROE by Quarter and Year

Discovering the peaks and valleys of Co-Diagnostics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Co-Diagnostics, Inc. (CODX) Average ROE

How has CODX ROE performed in the past?

The current ROE of Co-Diagnostics, Inc. (CODX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Co-Diagnostics, Inc. (CODX) ROE vs. Peers

How is CODX’s ROE compared to its peers?

Co-Diagnostics, Inc.’s ROE is greater than Heart Test Laboratories, Inc. (-144.10%), greater than NanoVibronix, Inc. (-101.17%), greater than Rapid Micro Biosystems, Inc. (-48.05%), greater than ThermoGenesis Holdings, Inc. (-762.31%), greater than Biomerica, Inc. (-84.62%), less than Nemaura Medical Inc. (37.24%), greater than Bluejay Diagnostics, Inc. (-155.68%), greater than Movano Inc. (-345.78%), greater than INVO Bioscience, Inc. (-1073.76%), greater than enVVeno Medical Corporation (-48.73%), greater than Tivic Health Systems, Inc. (-201.30%), greater than Bone Biologics Corporation (-221.43%), greater than Vivos Therapeutics, Inc. (-335.03%), greater than Senseonics Holdings, Inc. (-212.62%), greater than Inogen, Inc. (-27.38%), greater than ClearPoint Neuro, Inc. (-62.10%), greater than NeuroPace, Inc. (-205.41%), greater than Surmodics, Inc. (-9.56%), greater than CVRx, Inc. (-89.06%), greater than NeuroMetrix, Inc. (-42.56%), greater than ReShape Lifesciences Inc. (-179.83%), greater than Inspira Technologies Oxy B.H.N. Ltd. (-134.16%), less than OpGen, Inc. (120.18%),

Build a custom stock screener for Co-Diagnostics, Inc. (CODX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Co-Diagnostics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Co-Diagnostics, Inc. (CODX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Co-Diagnostics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.